CHIEF FINANCIAL OFFICER · Kiniksa Pharmaceuticals International, plc · Class A Ordinary Share
Side
SELL
Value
$391K
Shares
9,114
Price
$42.85
Executed
Feb 9, 2026
Disclosed
Feb 11, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 9 executedFeb 11, 2026 disclosed
KNSA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ragosa Mark filed this Form 4 reporting a open-market sale of KNSA on Feb 9, 2026. It became public on Feb 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
